Ocera Therapeutics, Inc. OCRX
No live quote for OCRX yet.
Revenue & Expenses
Latest period ending Dec 31, 2016 · select a line to chart its full history
Income statement
| Fiscal year | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 | FY 2013 Dec 31, 2013 | FY 2012 Dec 31, 2012 |
|---|---|---|---|---|---|
| 609.00K | 133.00K | 341.00K | 85.00K | 0 | |
| 609.00K | 133.00K | 341.00K | 85.00K | 0 | |
| -25.88M | -26.34M | -24.68M | -15.33M | -3.38M | |
| -26.89M | -26.52M | -23.43M | -17.51M | -3.61M | |
| -1.22 | -1.32 | -1.34 | -2.85 | -5.76 |
Balance sheet
| Fiscal year | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 | FY 2013 Dec 31, 2013 | FY 2012 Dec 31, 2012 |
|---|---|---|---|---|---|
| 24.65M | 35.95M | 10.15M | 15.56M | 2.30M | |
| 29.64M | 44.74M | 53.05M | 51.82M | 2.41M | |
| 13.90M | 13.34M | 2.91M | 6.69M | 3.47M | |
| 9.70M | 9.51M | 0 | 0 | 2.91M | |
| 15.74M | 31.39M | 50.15M | 45.13M | -62.81M |
Cash flow
| Fiscal year | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 | FY 2013 Dec 31, 2013 | FY 2012 Dec 31, 2012 |
|---|---|---|---|---|---|
| -22.10M | -20.61M | -20.32M | -11.99M | -4.00M | |
| 3.62M | 33.20M | -8.86M | -21.26M | 248.00K | |
| 7.17M | 13.20M | 23.78M | 46.49M | 2.94M | |
| -14.00K | -75.00K | -38.00K | -12.00K | -2.00K | |
| -11.31M | 25.79M | -5.41M | 13.23M | -811.00K |